These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 21838740

  • 1. Tardive dyskinesia and deficit schizophrenia.
    Telfer S, Shivashankar S, Krishnadas R, McCreadie RG, Kirkpatrick B.
    Acta Psychiatr Scand; 2011 Nov; 124(5):357-62. PubMed ID: 21838740
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.
    Go CL, Rosales RL, Caraos RJ, Fernandez HH.
    Parkinsonism Relat Disord; 2009 Nov; 15(9):655-9. PubMed ID: 19346155
    [Abstract] [Full Text] [Related]

  • 4. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I, Oumaya A, Bouguerra C, Mehdi F, Bellaaj R, Gallali S.
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [Abstract] [Full Text] [Related]

  • 5. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
    Novick D, Haro JM, Bertsch J, Haddad PM.
    J Clin Psychopharmacol; 2010 Oct; 30(5):531-40. PubMed ID: 20814320
    [Abstract] [Full Text] [Related]

  • 6. Reduced serum TNF alpha level in chronic schizophrenia patients with or without tardive dyskinesia.
    Tian L, Tan Y, Chen D, Lv M, Tan S, Soares JC, Zhang XY.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct 03; 54():259-64. PubMed ID: 24995685
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [New chemotherapy approaches to psychoses].
    Olié JP, Baylé FJ.
    Encephale; 1997 Apr 03; 23 Spec No 2():2-9. PubMed ID: 9273302
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK, Zalar B, Breskvar K, Dolzan V.
    J Psychopharmacol; 2006 Nov 03; 20(6):829-33. PubMed ID: 16478753
    [Abstract] [Full Text] [Related]

  • 13. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y, Fan CH, Deng HH, Hu SH, Lv DP, Li LH, Wang JJ, Lu XQ.
    Acta Pharmacol Sin; 2006 Mar 03; 27(3):328-32. PubMed ID: 16490169
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB, Caligiuri MP.
    J Clin Psychiatry; 1996 Apr 03; 57(4):167-73. PubMed ID: 8601552
    [Abstract] [Full Text] [Related]

  • 16. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG.
    Can J Psychiatry; 1994 Nov 03; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J, Arango C, Garcia-Garcia M, Rejas J, CLAMORS Study Collaborative Group.
    J Clin Psychiatry; 2010 Mar 03; 71(3):280-6. PubMed ID: 19895779
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.